Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasim Allel

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Nature Communications|June 29, 2026
Risk of incident tuberculosis after severe COVID-19: a nationwide cohort studySalvador Vargas-García, Lourdes García-García, Christian García, et al.
The Lancet. Global Health|April 15, 2022
National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010-19: a data envelopment and stochastic frontier analysisGerard Joseph Abou Jaoude, Ines Garcia Baena, Peter Nguhiu, et al.
Lancet Regional Health. Americas|November 28, 2024
Excess burden of antibiotic-resistant bloodstream infections: evidence from a multicentre retrospective cohort study in Chile, 2018-2022Kasim Allel, Anne Peters, Hassan Haghparast-Bidgoli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2026
Cost-effectiveness of conditional cash transfers with pre- and post-test tuberculosis counselling in South Africa: a modelling analysisLara Goscé, Elena Venero Garcia, Kasim Allel, et al.
Lancet Regional Health. Americas|April 20, 2026
Trends and drivers of multidrug-resistant bacteria incidence in 59 Chilean intensive care units, 2015-2024: a Bayesian hierarchical analysisMaria-Paz Acuña, Patricio Ross, Gerardo Carcamo, et al.
Journal of Travel Medicine|August 21, 2023
A decision support tool for risk-benefit analysis of Japanese encephalitis vaccine in travellersColleen L Lau, Deborah J Mills, Helen Mayfield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2025
Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled TrialCinthya Ruiz-Tagle, Romina Seguel, Luis Villarroel, et al.
Risk Management and Healthcare Policy|March 4, 2024
Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>: Risk Factors and Economic Burden Among Patients with Bloodstream InfectionsJiakang Chen, Kasim Allel, Chuyue Zhuo, et al.
BMJ Global Health|February 29, 2024
Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature reviewKasim Allel, María José Hernández-Leal, Nichola R Naylor, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|December 23, 2022
Global Pain and Aging: A Cross-Sectional Study on Age Differences in the Intensity of Chronic Pain Among Middle-Aged and Older Adults in 20 CountriesEsteban Calvo, Cynthia Córdova, Robin Shura, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Nature Communications|June 29, 2026
Risk of incident tuberculosis after severe COVID-19: a nationwide cohort studySalvador Vargas-García, Lourdes García-García, Christian García, et al.
The Lancet. Global Health|April 15, 2022
National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010-19: a data envelopment and stochastic frontier analysisGerard Joseph Abou Jaoude, Ines Garcia Baena, Peter Nguhiu, et al.
Lancet Regional Health. Americas|November 28, 2024
Excess burden of antibiotic-resistant bloodstream infections: evidence from a multicentre retrospective cohort study in Chile, 2018-2022Kasim Allel, Anne Peters, Hassan Haghparast-Bidgoli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2026
Cost-effectiveness of conditional cash transfers with pre- and post-test tuberculosis counselling in South Africa: a modelling analysisLara Goscé, Elena Venero Garcia, Kasim Allel, et al.
Lancet Regional Health. Americas|April 20, 2026
Trends and drivers of multidrug-resistant bacteria incidence in 59 Chilean intensive care units, 2015-2024: a Bayesian hierarchical analysisMaria-Paz Acuña, Patricio Ross, Gerardo Carcamo, et al.
Journal of Travel Medicine|August 21, 2023
A decision support tool for risk-benefit analysis of Japanese encephalitis vaccine in travellersColleen L Lau, Deborah J Mills, Helen Mayfield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2025
Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled TrialCinthya Ruiz-Tagle, Romina Seguel, Luis Villarroel, et al.
Risk Management and Healthcare Policy|March 4, 2024
Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>: Risk Factors and Economic Burden Among Patients with Bloodstream InfectionsJiakang Chen, Kasim Allel, Chuyue Zhuo, et al.
BMJ Global Health|February 29, 2024
Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature reviewKasim Allel, María José Hernández-Leal, Nichola R Naylor, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|December 23, 2022
Global Pain and Aging: A Cross-Sectional Study on Age Differences in the Intensity of Chronic Pain Among Middle-Aged and Older Adults in 20 CountriesEsteban Calvo, Cynthia Córdova, Robin Shura, et al.
Pageof 6